Development of a guideline on the quality aspects of mRNA vaccines - Scientific guideline
Draft guideline on the quality aspects of mRNA vaccines
Draft Reflection paper on linking to electronic product information (ePI) from EU medicine packages
Human medicines European public assessment report (EPAR): Amgevita, adalimumab, Date of authorisation: 21/03/2017, Revision: 14, Status: Authorised
EVVet3 EVWeb Production - Release notes
List of centrally authorised products with safety-related changes to the product information
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed
HMPC: overview of assessment work - priority list
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised
History of EMA